“We are pleased to report revenue of $205.5 million in the first quarter of 2020, along with an all-time record for gross margin, despite COVID-19. Our first quarter revenue increased 105% year-over-year. We shipped approximately 643 megawatts DC, or 2,012,476 microinverters, as our worldwide teams did an excellent job of ensuring product availability and on-time customer deliveries,” reported […]
Author: Ian Cooper
Fate Therapeutics (FATE) Announces Progress on Cancer Immunotherapy
Fate Therapeutics (FATE) is still seeing a good deal of momentum. Over the last few days, FATE announced the presentation of a new off-the-shelf, iPSC-derived, chimeric antigen receptor (CAR)-targeted cell-based cancer immunotherapy program at the American Society of Gene & Cell Therapy (ASGCT) 23rd Annual Meeting. The new preclinical program targets MHC class I related […]
Zynga Inc. (ZNGA) Signs First Deal With Amazon (AMZN) On Words With Friends 2
Zynga (ZNGA) just teamed up with Amazon.com to offer promotional content to prime subscribers. In fact, ZNGA just debuted its Words With Friends 2 content for Amazon Prime subscribers earlier this week. “This is our first deal working with Amazon (AMZN), and it’s similar to a lot of Twitch Prime deals in the market already,” […]
Electric Car Maker Nio Inc. (NIO) Sees 117% Month Over Month Growth
Shares of electric vehicle maker, Nio (NIO) have been under pressure. All on news China will cut subsidies on new energy vehicles, such as electric cars, by 10% this year. Under China’s new plan, it will also extend subsidies for buying NEVs to 2022, and tax exemptions on purchases for two years. NIO has also […]
Analysts Predict Zynga Inc. (ZNGA) Will Continue to Benefit from COVID-19 Outbreak
Video games are still thriving in the spotlight. One of the top ones has been Zynga (ZNGA), which ran from a low of $5.80 to $7.80. All on the heels of the coronavirus and a World Health Organization note to play more video games. “We’re at a crucial moment in defining outcomes of this pandemic. […]
Fate Therapeutics (FATE) Secures $3 Billion in Deal With Johnson & Johnson (JNJ) Subsidiary
Just last week, the FATE finished up more than 8% at $22.94 after securing a $3 billion deal with Janssen Biotech, Inc, one of the Janssen Pharmaceutical Companies of Johnson & Johnson to develop four cancer treatments. These treatments belong to a class known as immuno-oncology drugs, which help teach the immune system how to […]
5 Popular Stocks Now Trading as Penny Stocks Thanks to Coronavirus
Coronavirus fear became palpable. Panicked investors sent major indices down thousands of points, reducing former high-flying stocks to penny stock status. All thanks to an invisible virus that’s making its way around the world. But what we have to remember is that the virus will pass – and that markets will bounce back. Granted, we […]
The Dow Jones Industrial Average Hits Three-Year Low While Volatility Remains
For the major indices to stop falling, investors need to see a solution to the crippling spread, and progress from Congress. The Federal Reserve has tried to help. Just this morning, the Federal Reserve announced limitless asset purchases to keep the markets functioning. The central bank will run in the “amounts needed to support smooth […]
These Growth Stocks Are Perfectly Position For a Country Staying Home
With coronavirus cases increasing, governments are advising “social distancing” to halt the spread. In short, “you can lower your risk of infection by reducing your rate of contact with other people. Avoiding public spaces and unnecessary social gatherings, especially events with large numbers of people or crowds, will lower the chance that you will be […]
Epic Levels of Fear Produce a 1,200% Winner In a Matter of Weeks
To help, the Federal Reserve cut interest rates to zero, and announced a massive $700 billion bond buying program. Unfortunately, it may not have been enough. “The Fed is trying to be preemptive to calm the markets, but what’s worrisome to me is that they’ve unloaded the gun and there are no bullets left. If […]